June 12, 2019 — History News Network interviews UW ADRC's Dr. Tom Bird, a medical pioneer in Huntington's disease, an inherited neurodegenerative condition. Dr. Bird talks about his new book Can You Help Me?, medical ethics, clinical compassion, and many intriguing patient stories.
Read: New ADRC publication helps explain why some brains are resilient, or can function normally despite Alzheimer’s disease.
June 10, 2019 — Latimer et al. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathologica Communications 2019 7:9
June 03, 2019 — Towards use of transcranial, near-diagnostic ultrasound to treat dementia
May 23, 2019 — New resources, findings, and funding opportunities from the National Centralized Repository for ADRD.
May 16, 2019 — August 12-13th, we will hold our 7th annual ACT Symposium, highlighting aging and dementia research from the long-standing Adult Changes in Thought cohort and affiliated studies (PIs Eric Larson and Paul Crane). The theme of this year’s symposium is “Celebrating 25 years of collaborative research on aging and dementia”. The call for abstracts and proposals is now open!
May 16, 2019 — Explore ADORE, the NIA repository of resources to support the recruitment and retention of participants into clinical trials and studies on Alzheimer’s disease and related dementias.
May 15, 2019 — On May 21 7pm at Folio, Dr. Thomas Bird, MD, Emeritus, UW Neurology, will share the surprising, insightful, challenging, and even encouraging stories of patients and their families who live with Huntington's Disease. Dr. Bird has helped HD patients for more than 40 years.
April 30, 2019 — A new paper in Brain describes a newly recognized mimic of Alzheimer's disease in older adults: Limbic-predominant age-related TDP-43 encephalopathy (LATE). Contributions to this work by ADRC neuropathologist Dr. C. Dirk Keene.
April 24, 2019 — The May 9 MODEL-AD Annual #Alzheimers Symposium will focus on the study of risk and resilience w/ new animal models. The free event features speakers from the UW ADRC, Jackson labs, Rush University, Indiana University, and SageBio.
April 10, 2019 — Register for the April 29th Allen Brain Inst. Distinguished Seminar Series Ivan Soltesz, PhD, Stanford University School of Medicine. His lab focuses on nature of inhibition in the CNS, the synaptic and cellular organization of GABAergic microcircuits in the hippocampus under normal conditions and in temporal lobe epilepsy, using experimental and theoretical techniques.